Vaxinnate Corporation
- UEI
- K61HKG4JFH99
- CAGE
- 334V4
- Primary NAICS
- 541711 Research and Development in Biotechnology
- SAM.gov registration
- Expired
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Website
- vaxinnate.com
- Founded
- 2002
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $0 |
| FY2025 | -$31,732,480 |
Contract awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Biomedical (advanced) | Office of the Assistant Secretary for Preparedness and Response | $86,180,679 | |
| Establish a pipeline of new adjuvant leads | NIAID DEA OA Acquisitions (NIH) | $4,361,059 |
Grant awards
Quick answers
Is Vaxinnate Corporation registered in SAM.gov?
Vaxinnate Corporation's SAM.gov registration expired on July 6, 2018.
What is Vaxinnate Corporation's most recent federal award?
Vaxinnate Corporation's most recent federal grant award is Development of a recombinant zika virus vaccine based on subunit envelope (e) amtigen fused to a TLR5 agonist… (R21AI128960), from National Institutes of Health, on August 18, 2016.
On GovTribe
See Vaxinnate Corporation's full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors